Navigation Links
Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms
Date:7/27/2009

led Phase 3 study that evaluated 3,397 healthy, postmenopausal women with an intact uterus aged 40 to 75 years. The primary end point of the SMART-1 trial was incidence of endometrial hyperplasia at one year. Secondary end points included bone mineral density (BMD) at two years, menopausal vasomotor symptoms at four and 12 weeks, vaginal maturation index at six months, menopause-related quality of life measures, and overall safety and tolerability. The results were published concurrently across four manuscripts at http://www.fertstert.org/inpress.

Titles and Summary of Findings From Published Manuscripts

1. Endometrial Protection in Menopausal Therapy with a Tissue Selective Estrogen Complex (TSEC) Containing Bazedoxifene/Conjugated Estrogens (Pickar JH, et al)

To evaluate endometrial effects, biopsies were performed at screening and at months six, 12, and 24, or when subjects withdrew from the study and more than three months had elapsed since their last assessment. Treatment with BZA/CE doses being considered for therapeutic use were associated with rates of endometrial hyperplasia <1%. These rates were not significantly different from those reported with placebo over two years of study.

2. Bazedoxifene/Conjugated Estrogens (BZA/CE): Incidence of Uterine Bleeding in Postmenopausal Women (Archer DF, et al)

To evaluate the effect of treatment with BZA/CE on uterine bleeding, trial participants were asked to record in a diary whether or not they experienced bleeding and/or spotting. The mean number of bleeding or spotting days with BZA/CE was not statistically different from placebo over two years of therapy.

3. Evaluation of Bazedoxifene/Conjugated Estrogens (BZA/CE) for the Treatment
'/>"/>

SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
3. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
4. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
5. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
6. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
9. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
10. Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
11. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014  Semler Scientific, Inc. (Nasdaq: ... risk assessment company that develops patented products that ... chronic diseases, today reported financial results for the ... 2014. "The second quarter of ... Doug Murphy-Chutorian , M.D., chief executive officer ...
(Date:7/25/2014)... -- Dr. Michael Gabriel of a prominent ... recent study, which shows how grief in pregnancy may cause ... According to US News , "Unborn ... than others to grow up overweight or obese, even if ... two specific types of stress that caused obesity: "Children whose ...
(Date:7/24/2014)...  Restore Health, a leading personalized medicine company ... it is now offering pharmacogenetics testing that provides ... upon their particular genetic makeup. Comprehensive medication management ... a patient,s genetics and their entire drug regimen.  ... this new service to healthcare providers and their ...
Breaking Medicine Technology:Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3
(Date:7/25/2014)... News) -- The human brain can preserve oxygen to ... study finds. Although dehydration significantly reduces blood ... that the brain compensates by increasing the amount of ... has helped us understand a lot more about how ... conditions," study first author Steven Trangmar, a researcher at ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Art of Facial ... services to those in Toronto who are looking for minor ... study done by the American Academy of Facial Plastic ... 2014, interest in facial plastic surgery showed a surprising increase ... rose 10 percent, while hair transplants increased by 7 percent ...
(Date:7/25/2014)... A new study of participants in the National Lung Screening ... Cancer , found evidence that men and women between ... finding on a lung cancer screening test did not experience ... who were screened and found to be cancer-free. , ... expected that participants with an abnormal finding would be more ...
(Date:7/25/2014)... nearly 27,000 older adults on five continents found that ... on a simple test that measures how fast people ... tested positive for pre-dementia were twice as likely as ... led by scientists at Albert Einstein College of ... Center , was published online on July 16, 2014 ...
(Date:7/25/2014)... July 25, 2014 Drexel University College ... Weber, MD, MS, FACP, has been appointed vice dean for ... join Drexel from The Commonwealth Medical College, where she is ... for clinical affairs, and professor of medicine. , As ... Medical College, Weber had a major role in many aspects ...
Breaking Medicine News(10 mins):Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5Health News:Slow walking speed and memory complaints can predict dementia 2Health News:Slow walking speed and memory complaints can predict dementia 3Health News:Slow walking speed and memory complaints can predict dementia 4Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 2Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 3
... ... ... Cornerstone Healthcare Partners has entered into an agreement with the Orthopedic Institute ... the Orthopedic Hospital, effective January 1, 2010, reports Houshang Seradge, MD. Cornerstone is ...
... following statement upon passage tonight by the House of Representatives of historic healthcare reform legislation: , ... , , ... ... "Today, America ...
... Life Action President & CEO Dr. Charmaine Yoest : , ... , , ... ... "Today, Congress ignored the explicit wishes of ...
... study has found that when African American and white ... institutions, mortality rates are roughly equal. Published early online ... American Cancer Society, the findings suggest that where patients ... cancer mortality. In the new study, researchers led ...
... ... the United States, recently unveiled its new DRASH medical surge facility at the 2010 Pasadena ... Pasadena, ... in the United States, recently unveiled its new DRASH medical surge facility at ...
... five-center collaborative study that scanned the genomes of thousands of "never ... has found a gene they say could be responsible for a ... line issue of Lancet Oncology , the researchers ... who developed lung cancer had the same uncommon variant, or allele, ...
Cached Medicine News:Health News:Cornerstone Health Corporation Named Manager of Orthopedic Institute's Hospital and Tower Day Surgery Center 2Health News:Rep. Fattah Says Healthcare Reform Will Work, But Get Ready for Nonsensical Talk About Repeal 2Health News:Pro-Life Leader Dr. Charmaine Yoest on House Passage of Health Care Legislation 2Health News:Racial disparities diminish in specialized cancer centers 2Health News:DRASH Keeps Marathon Runners On Track 2Health News:DRASH Keeps Marathon Runners On Track 3Health News:Gene is linked to lung cancer development in never-smokers 2Health News:Gene is linked to lung cancer development in never-smokers 3Health News:Gene is linked to lung cancer development in never-smokers 4
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... family of Pacemakers, Ela presents the most ... than a passport, will take your patients ... and delivering powerful monitoring. ELA dual chamber ... atrial tracking modes in patients who may ...
... New Exclusive Measuring System delivers precise and ... they are receiving a better examination when ... latest Hi-tech equipment. ,User Friendly - after ... office personnel can become very proficient in ...
Great for small incisions and excision needs...
Medicine Products: